BeStock  
Stocks › Biotechnology › NVCT

Nuvectis Pharma NVCT

US equityMarket cap rank #3552Biotechnology
$20.29 +$0.26 (+1.30%)
Market closed · Oct 8, 5:40 am ET · Last extended-hours $20.29 0.00%
Open$19.67
Prev close$20.03
Day range$19.67 – $20.72
Volume121.1K
Market cap$662.35M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership33.7%-4.91 pts vs. prior quarter
Institutions holding105+1 vs. prior quarter
Insider trades (recent)44 buys / 1 sellsNet buying
Short interest7.24% of floatDays to cover 14.8 · as of 15 Sep 2026
Short-sale volume share28.9%5-day average of daily volume

Short-sale volume as % of daily volume

18%27%36%44%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$485.8K (12 inflow days, 8 outflow days).

Net flow by order size, last 20 sessions

+$463.0KSuper+$22.8KBig−$33.0KMid+$888.0KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 37.2% of shares outstanding.

Largest holders

  • Ron Bentsur11.32%
  • Charles Mosseri-Marlio10.12%
  • Enrique Poradosu5.54%
  • Shay Shemesh5.50%
  • Tang Capital Management, LLC4.76%
  • Soleus Capital Management, L.P.4.60%
  • BlackRock3.07%
  • Vanguard Capital Management, LLC3.07%

By investor type

  • Individual/Insider34.92%
  • Mutual Fund19.25%
  • Hedge Fund9.06%
  • VC/PE Fund3.84%
  • Private Company1.07%
  • Public Company0.21%
  • Insurance Company0.13%
  • Government Pension Fund0.12%

Reported short interest has risen from 6.80% to 7.24% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Soleus Capital Management, L.P. Hedge Fund 2026/Q3 +498,024 4.6%
Soleus Capital LLC VC/PE Fund 2026/Q3 +150,000 0.5%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +40,823 0.1%
Tang Capital Management, LLC Mutual Fund 2026/Q3 +1,550,000 4.8%
Perceptive Advisors LLC VC/PE Fund 2026/Q3 +1,000,000 3.1%
Sphera Funds Management Ltd Hedge Fund 2026/Q3 +382,945 1.2%
Alyeska Investment Group, L.P. Hedge Fund 2026/Q3 +275,000 0.8%
BlackRock Mutual Fund 2026/Q3 +236,844 3.1%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +225,315 3.1%
Avidity Partners Management, L.P. Hedge Fund 2026/Q3 +200,000 0.6%
Iridian Asset Management LLC Mutual Fund 2026/Q3 +125,321 2.4%
Susquehanna International Group, LLP Private Company 2026/Q3 +112,000 0.7%
Kalehua Capital Management LLC VC/PE Fund 2026/Q3 +100,000 0.3%
State Street Global Advisors Mutual Fund 2026/Q3 +81,682 0.8%
Charles Mosseri-Marlio Individual/Insider 2026/Q3 +50,000 10.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
2 Aug 2026 Michael Carson Officer Other Acquisition +30,000 – 230,118
29 Jun 2026 Ron Bentsur Chairperson & CEO Open Market Acquisition +12,500 $20.00 3,688,424
29 Jun 2026 Charles Mosseri-Marlio Open Market Acquisition +50,000 $18.32 3,295,897
10 Jun 2026 James Oliviero Independent Director Other Acquisition +35,000 – 122,828
10 Jun 2026 Matthew Kaplan Independent Director Other Acquisition +35,000 – 159,760
10 Jun 2026 Juan Sanchez Director Other Acquisition +35,000 – 113,795
10 Jun 2026 Kenneth Hoberman Independent Director Other Acquisition +35,000 – 168,140
5 Jan 2026 Ron Bentsur Chairperson & CEO Other Acquisition +150,000 – 3,605,924
5 Jan 2026 Enrique Poradosu Co-Founder, Executive VP, Chief Scientific & Business Officer Other Acquisition +150,000 – 1,767,986
5 Jan 2026 Michael Carson Officer Other Acquisition +61,200 – 200,118
5 Jan 2026 Shay Shemesh Co-Founder, Executive VP, Chief Development & Operations Officer Other Acquisition +150,000 – 1,754,735
4 Nov 2025 Ron Bentsur Chairperson & CEO Open Market Acquisition +5,000 $5.72 3,455,924
4 Nov 2025 Matthew Kaplan Independent Director Open Market Acquisition +11,000 $5.84 124,760
4 Nov 2025 Juan Sanchez Director Open Market Acquisition +13,000 $5.79 78,565
26 Oct 2025 Charles Mosseri-Marlio Open Market Acquisition +154,770 $6.28 3,245,897
21 Sep 2025 Juan Sanchez Director Other Acquisition +30,000 – 65,565
21 Sep 2025 Juan Sanchez Director Initial Statement of Beneficial +0 – 35,565
19 Jun 2025 Charles Mosseri-Marlio Open Market Acquisition +5,603 $7.99 3,091,127
17 Jun 2025 Charles Mosseri-Marlio Open Market Acquisition +33,442 $8.11 2,976,203
11 Jun 2025 James Oliviero Independent Director Other Acquisition +30,000 – 87,828

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 2,362,527 7.2% 14.8
31 Aug 2026 2,196,224 6.7% 9.3
14 Aug 2026 1,836,385 5.6% 9.2
31 Jul 2026 1,843,596 5.8% 7.4
15 Jul 2026 1,512,192 4.8% 4.0
30 Jun 2026 1,802,732 6.8% 2.3

Discussion

No comments yet — be the first to weigh in on NVCT.

Leave a comment

Scroll to Top